妊娠相关骨折:法国52例患者队列的回顾性研究及文献综述
该回顾性多中心研究纳入52例妊娠相关骨质疏松患者,平均年龄32.1岁,平均椎体骨折3.8±2.0个,多发于妊娠晚期或分娩时。多数患者孕前或孕期存在危险因素,骨密度以骨小梁区骨质疏松为主,双膦酸盐或特立帕肽治疗可显著提高骨密度。
要点
- 妊娠相关骨质疏松常表现为多发椎体骨折,平均3.8±2.0个,多发生于妊娠晚期或分娩时。
- 52例中33例孕前存在低骨量危险因素,12例孕期有促骨质疏松疾病或肝素治疗,14例无明确诱因。
- 双膦酸盐或特立帕肽治疗可改善骨密度恢复,脊柱年增益分别约10%和15%。
核心结论
- 妊娠相关骨质疏松导致多发椎体骨折,常由孕前或孕期危险因素促发,机制尚不明确。
- 双膦酸盐或特立帕肽治疗似乎可改善骨密度恢复。
研究设计与样本
- 回顾性多中心研究,纳入法国6所大学医院风湿科近10年收治的52例妊娠相关骨质疏松女性患者。
主要发现
- 患者骨折时平均年龄32.1岁;10例骨折发生于妊娠晚期,36例发生于分娩时或产后前2个月。
- 平均椎体骨折数为3.8±2.0个;52例中33例孕前存在低骨量危险因素,12例孕期有促骨质疏松疾病或治疗(肝素),14例无孕前或孕期触发因素。
- 血磷和血钙总体正常,但哺乳期女性高磷血症占90%;双能X线吸收检测法显示骨质疏松以骨小梁为主,脊柱T值为-3.4,髋部T值为-2。
- 仅10例患者发生再骨折,随访期间骨密度增加显著,双膦酸盐治疗者脊柱年增益+10%,特立帕肽治疗者+15%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: A retrospective, multicentre study involving 52 patients was carried out to define the causes and characteristics of pregnancy-related osteoporosis. The mean number of vertebral fractures occurring during the last trimester of pregnancy or at the time of delivery was 3.8. This is often promoted by risk factors before or during pregnancy. INTRODUCTION: In order to define the causes or predisposing factors of pregnancy-related osteoporosis and its clinical, radiological and bone density characteristics, laboratory findings, course and outcome, we carried out a retrospective multicentre study. METHODS: The records of 52 women hospitalised over the last 10 years in the rheumatology departments of six French university hospitals and with a diagnosis of pregnancy-related osteoporosis were examined. RESULTS: The patients' mean age at time of fracture was 32.1 years. In 10 patients, the fractures had occurred during the last trimester of pregnancy, and in 36 at the time of delivery or during the first 2 months post-partum. The mean number of vertebral fractures was 3.8 ± 2.0. Thirty three of the 52 patients had a risk factor of low bone mass before pregnancy. Twelve had disorders or treatments (heparin) that might promote osteoporosis during pregnancy, while 14 had no trigger factors before or during pregnancy. Overall, phosphate and calcium levels were normal, except for hyperphosphoraemia in lactating women (90%). On DXA scan, osteoporosis predominated in the trabecular bone (spinal T-score - 3.4, hip T-score - 2). Only 10 patients had a repeat fracture, and the increase in bone mineral density during follow-up was considerable, and improved by bisphosphonates (annual gain + 10% in the spine) or teriparatide (+ 15%). CONCLUSIONS: Pregnancy-related osteoporosis gives rise to multiple vertebral fractures. It is often promoted by risk factors before or during pregnancy. Its mechanism is still unknown. Treatment with bisphosphonates or teriparatide appears to improve the recovery of bone mineral density.
引用
- Laroche M, Talibart M, Cormier C, et al. Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature. Osteoporos Int. 2017. PMID: 28879474. doi:10.1007/s00198-017-4165-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。